ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Horizon Therapeutics plc announces premium partnership with KPMG Women’s Irish Open

Horizon Therapeutics plc (Nasdaq: HZNP) today announced its partnership for the 2023 KPMG Women’s Irish Open held at Dromoland Castle from August 31 to September 3. The leading Ladies European Tour (LET) event tees up a week prior to the Horizon Irish Open and will draw Europe's leading professional female golfers who will go head to head for a total prize fund of €400,000.

“We are delighted to announce our partnership with the KPMG Women’s Irish Open, which further strengthens our commitment to golf in Ireland and globally. Ensuring a positive impact on the communities in which we operate and building the highest performing diverse teams is core to how we operate at Horizon, and we believe this partnership underlines these values,” said Tim Walbert, chairman, president and chief executive officer, Horizon.

“Our existing work with partners like Pádraig Harrington, Shane Lowry, Seamus Power and Brendan Lawlor, alongside our title sponsorship of the Horizon Irish Open, means that this partnership is a natural next step in our support for the game. As a company we are dedicated to ensuring excellence in all that we do so it has been fantastic to see so many high calibre players announced for the tournament already. We are really looking forward to what will be a week of incredible golf.”

“We are thrilled that Horizon have partnered with the 2023 KPMG Women’s Irish Open this year,” commented tournament director and chief executive officer at Forefront Sports, Cian Branagan. “For years, Horizon have demonstrated their enthusiastic support for golf in Ireland, most notably by being the title sponsor of the Men’s Horizon Irish Open, and now showcasing their support of women’s golf by joining forces with the KPMG Women’s Irish Open.”

“We are honoured to welcome Horizon as a proud sponsor of the KPMG Women's Irish Open at Dromoland Castle,” said Mark Nolan, managing director of Dromoland Castle. “This partnership signifies an important milestone in our journey towards promoting equality and diversity in golf. With Horizon's support, we will amplify the visibility of women's golf, encourage participation, and pave the way for a more inclusive future in the sport. We look forward to a phenomenal tournament ahead.”

The highly anticipated event is offering both general admission and hospitality tickets throughout the week which are available on the official event website and under 16s will get in for free once accompanied by an adult.

To secure your tickets and keep up to date with the latest player announcements for the KPMG Women’s Irish Open, please visit www.kpmgwomensirishopen.ie. You can also follow the tournament via social media by following @kpmgwomensopen on Instagram and Facebook and @womensirishopen on Twitter and TikTok.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.